Related Experiment Video
Updated: Dec 8, 2025

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns
Lene Pålhaugen1,2, Carole H Sudre3,4,5, Sandra Tecelao1
1Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
Abstract:
White matter hyperintensities (WMHs) are associated with vascular risk and Alzheimer's disease. In this study, we examined relations between WMH load and distribution, amyloid pathology and vascular risk in 339 controls and cases with either subjective (SCD) or mild cognitive impairment (MCI). Regional deep (DWMH) and periventricular (PWMH) WMH loads were determined using an automated algorithm. We stratified on Aβ1-42 pathology (Aβ+/-) and analyzed group differences, as well as associations with Framingham Risk Score for cardiovascular disease (FRS-CVD) and age. Occipital PWMH (p = 0.001) and occipital DWMH (p = 0.003) loads were increased in SCD-Aβ+ compared with Aβ- controls. In MCI-Aβ+ compared with Aβ- controls, there were differences in global WMH (p = 0.003), as well as occipital DWMH (p = 0.001) and temporal DWMH (p = 0.002) loads. FRS-CVD was associated with frontal PWMHs (p = 0.003) and frontal DWMHs (p = 0.005), after adjusting for age. There were associations between global and all regional WMH loads and age. In summary, posterior WMH loads were increased in SCD-Aβ+ and MCI-Aβ+ cases, whereas frontal WMHs were associated with vascular risk. The differences in WMH topography support the use of regional WMH load as an early-stage marker of etiology.
Insights
White matter hyperintensities (WMHs) linked to Alzheimer's disease show distinct patterns. Posterior WMHs are elevated in early Alzheimer's stages with amyloid pathology, while frontal WMHs correlate with cardiovascular risk.
Area of Science:
- Neurology
- Neuroimaging
- Alzheimer's Disease Research
Background:
- White matter hyperintensities (WMHs) are common neuroimaging findings.
- WMHs are associated with vascular risk factors and Alzheimer's disease (AD).
- Understanding WMH distribution and its relation to AD pathology and vascular risk is crucial for early diagnosis.
Purpose of the Study:
- To investigate the relationship between white matter hyperintensity (WMH) load and distribution.
- To examine associations with amyloid-beta (Aβ) pathology and cardiovascular disease risk.
- To determine if regional WMH patterns differ in individuals with subjective cognitive decline (SCD) or mild cognitive impairment (MCI) based on Aβ status.
Main Methods:
- Utilized an automated algorithm to quantify regional deep (DWMH) and periventricular (PWMH) WMH loads in 339 participants.
- Stratified participants based on amyloid-beta (Aβ) pathology (Aβ+/-).
- Analyzed group differences and associations with Framingham Risk Score for cardiovascular disease (FRS-CVD) and age.
Main Results:
- Increased occipital PWMH and DWMH loads were observed in SCD with Aβ+ compared to controls without Aβ.
- MCI with Aβ+ showed differences in global WMH, occipital DWMH, and temporal DWMH loads compared to MCI without Aβ.
- Frontal PWMHs and DWMHs were associated with FRS-CVD, independent of age.
- Global and regional WMH loads were associated with age.
Conclusions:
- Posterior WMH loads are elevated in individuals with early cognitive decline and positive amyloid pathology.
- Frontal WMH distribution is linked to cardiovascular risk factors.
- Regional WMH topography may serve as an early indicator of disease etiology in cognitive impairment.
More Related Videos
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
05:12A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
Related Concept Videos
Amyloid Fibrils
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...